FDA data Registry peer set 3 peers

Alternatives to glycopyrrolate

3 same-class SPL records vs glycopyrrolate - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Seebri, Lonhala

Long-Acting Muscarinic Antagonist (LAMA) Prescription 3 alternatives found

About glycopyrrolate

Glycopyrrolate injection reduces body secretions before and during surgery. It can also help manage peptic ulcers in adults when quick action is needed.

Used for: This medicine can help reduce saliva and other secretions before surgery. It can also help control stomach acid. Glycopyrrolate can also treat peptic ulcers in adults when a quick effect is needed or when you can't take pills.

3 Long-Acting Muscarinic Antagonist (LAMA) peers (wide set)

Compare glycopyrrolate vs aclidinium side-by-side →

glycopyrrolate vs aclidinium & tiotropium · FAERS reaction fields

FAERS top-reaction field "Asthma" shows the widest count spread between glycopyrrolate and aclidinium, tiotropium, umeclidinium in this extract (10,024-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect glycopyrrolate aclidiniumtiotropiumumeclidinium
Dyspnoea 1,000 - - 1,352
Asthma 793 814 10,817 604
Wheezing 674 645 6,761 325
Cough 626 655 8,611 701
Pneumonia 538 692 8,380 509
Fatigue 352 - - 364
Malaise 345 - - 315
Productive Cough 330 - - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

glycopyrrolate peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for Long-Acting Muscarinic Antagonist (LAMA): 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside glycopyrrolate?
This registry lists 3 Long-Acting Muscarinic Antagonist (LAMA) medication records beside glycopyrrolate, including aclidinium, tiotropium, umeclidinium. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Long-Acting Muscarinic Antagonist (LAMA) peer set (3 records)

glycopyrrolate (Seebri, Lonhala) sits in a wide Long-Acting Muscarinic Antagonist (LAMA) peer set (3 of 3 class peers shown). Labeled indication field for glycopyrrolate: This medicine can help reduce saliva and other secretions before surgery.

Top FAERS reaction fields for glycopyrrolate total 5,311 reports across 10 reactions, set beside aclidinium, tiotropium, umeclidinium. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full glycopyrrolate profile →

Field note for glycopyrrolate: see also the generic vs brand label guide when reading Seebri SPL strings.